GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (FRA:5JD0) » Definitions » 3-Year ROIIC %

ExpreS2ion Biotech Holding AB (FRA:5JD0) 3-Year ROIIC % : 2,317.60% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is ExpreS2ion Biotech Holding AB 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. ExpreS2ion Biotech Holding AB's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 2,317.60%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for ExpreS2ion Biotech Holding AB's 3-Year ROIIC % or its related term are showing as below:

FRA:5JD0's 3-Year ROIIC % is ranked better than
97.5% of 1358 companies
in the Biotechnology industry
Industry Median: -13.43 vs FRA:5JD0: 2317.60

ExpreS2ion Biotech Holding AB 3-Year ROIIC % Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB 3-Year ROIIC % Chart

ExpreS2ion Biotech Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -302.69 -263.84 935.34 -2,099.04 2,317.60

ExpreS2ion Biotech Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2,317.60 - - -

Competitive Comparison of ExpreS2ion Biotech Holding AB's 3-Year ROIIC %

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ExpreS2ion Biotech Holding AB's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's 3-Year ROIIC % falls into.



ExpreS2ion Biotech Holding AB 3-Year ROIIC % Calculation

ExpreS2ion Biotech Holding AB's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -8.6611639 (Dec. 2023) - -2.783928 (Dec. 2020) )/( 1.75 (Dec. 2023) - 2.214 (Dec. 2020) )
=-5.8772359/-0.464
=1,266.65%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


ExpreS2ion Biotech Holding AB  (FRA:5JD0) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


ExpreS2ion Biotech Holding AB 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


ExpreS2ion Biotech Holding AB Business Description

Traded in Other Exchanges
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB Headlines

No Headlines